Mixture-of-Recursions (MoR) is a new AI architecture that promises to cut LLM inference costs and memory use without ...

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals – Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – ...